Resistin is associated with mortality in patients with traumatic brain injury

Critical Care

Volumn 14, Issue 5, 2010, Pages

  Dong, Xiao Qiao ^a   Yang, Song Bin ^b   Zhu, Fang Long ^b   Lv, Qing Wei ^b   Zhang, Guo Hai ^b   Huang, Hang Bin ^b  

^a The First Hangzhou Municipal People's Hospital   (China)

^b Shengzhou People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RESISTIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; COMPARATIVE STUDY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; CHILD; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; RESISTIN; YOUNG ADULT;

EID: 77958593115     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9307     Document Type: Article

References (21)

1. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001, 98:502-506. 10.1073/pnas.98.2.502, 14616, 11209052.
2. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001, 276:11252-11256. 10.1074/jbc.C100028200, 11278254.
3. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312. 10.1038/35053000, 11201732.
4. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003, 300:472-476. 10.1016/S0006-291X(02)02841-3, 12504108.
5. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001, 288:1027-1031. 10.1006/bbrc.2001.5874, 11689013.
6. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003, 309:286-290. 10.1016/j.bbrc.2003.07.003, 12951047.
7. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002, 530:158-162. 10.1016/S0014-5793(02)03450-6, 12387885.
8. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
9. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem Biophys Res Commun 2005, 334:1092-1101. 10.1016/j.bbrc.2005.06.202, 16039994.
10. Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 2006, 3:29-34.
11. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939. 10.1161/01.CIR.0000155620.10387.43, 15710760.
12. Wilkinson M, Brown R, Imran SA, Ur E. Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007, 86:191-209. 10.1159/000108635, 17878708.
13. Wiesner G, Brown RE, Robertson GS, Imran SA, Ur E, Wilkinson M. Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport 2006, 17:1195-1198. 10.1097/01.wnr.0000224776.12647.ba, 16837853.
14. Brown R, Thompson HJ, Imran SA, Ur E, Wilkinson M. Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci Lett 2008, 432:73-78. 10.1016/j.neulet.2007.12.008, 2367125, 18178314.
15. Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta 2007, 378:78-85. 10.1016/j.cca.2006.10.023, 17173885.
16. Dong XQ, Hu YY, Yu WH, Zhang ZY. High concentrations of resistin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. J Crit Care 2010, 25:243-247. 10.1016/j.jcrc.2009.09.008, 19903588.
17. Juul N, Morris GF, Marshall SB, Marshall LF. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000, 92:1-6. 10.3171/jns.2000.92.1.0001, 10616075.
18. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004, 56:1058-1062. 10.1097/01.TA.0000123267.39011.9F, 15179246.
19. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348-1353.
20. Marshall LF, Marshall SB, Klauber MR, Clark MV. A new classification of head injury based on computerized tomography. J Neurosurg 1991, 75:S14-S20.
21. Moppett IK. Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 2007, 99:18-31. 10.1093/bja/aem128, 17545555.